Valuation: Implanet SA

Market Cap 22.72M 25.56M 21.06M 19.16M 36.16M 2.43B 36.74M 253M 99.26M 1.27B 95.94M 93.9M 4.04B P/E 2024
-2.85x
P/E 2025 -5.8x
Enterprise Value 25.64M 28.84M 23.76M 21.62M 40.8M 2.74B 41.45M 286M 112M 1.43B 108M 106M 4.55B EV / Sales 2024
2x
EV / Sales 2025 2.23x
Free-Float
33.85%
Yield 2024 *
-
Yield 2025 -
1 day-2.53%
1 week-2.53%
Current month-3.75%
1 month-10.36%
3 months-13.39%
6 months-28.54%
Current year-22.42%
1 week 0.14
Extreme 0.142
0.19
1 month 0.14
Extreme 0.14
0.19
Current year 0.14
Extreme 0.14
0.29
1 year 0.14
Extreme 0.14
0.3
3 years 0.04
Extreme 0.035
0.45
5 years 0.04
Extreme 0.035
0.58
10 years 0.04
Extreme 0.035
56.8
Manager TitleAgeSince
Chief Executive Officer - 26/11/2012
Director of Finance/CFO - 31/08/2015
Chief Operating Officer - -
Director TitleAgeSince
Chairman 71 05/04/2011
Director/Board Member - 21/01/2013
Director/Board Member - 09/06/2014
Change 5-day change 1-year change 3-year change Capi.($)
-2.53%-2.53%-46.15%+151.63% 25.46M
-0.32%+4.81%-18.21%+13.25% 181B
-1.07%+6.69%-0.68%+31.56% 117B
+0.49%+6.32%-20.15%+11.65% 112B
+3.83%+5.50%-44.18%-6.77% 76.56B
+0.00%+5.34%+6.80%+82.56% 65.15B
+2.79%+2.50%+19.39%+64.11% 52.79B
-1.65%+3.88%+3.03%-26.51% 52.78B
+2.36%+8.19%-12.07%+30.46% 43.11B
-0.16%+0.66% - - 32.08B
Average +0.37%+4.62%-12.47%+39.10% 73.3B
Weighted average by Cap. +0.45%+5.70%-11.30%+22.20%

Financials

2024 2025
Net sales 9.41M 10.58M 8.72M 7.93M 14.97M 1B 15.21M 105M 41.09M 524M 39.71M 38.87M 1.67B 12.47M 14.03M 11.56M 10.52M 19.85M 1.33B 20.17M 139M 54.49M 695M 52.67M 51.54M 2.22B
Net income -4.37M -4.91M -4.05M -3.68M -6.95M -466M -7.06M -48.64M -19.07M -243M -18.43M -18.04M -775M -4.38M -4.93M -4.06M -3.7M -6.97M -468M -7.08M -48.82M -19.14M -244M -18.5M -18.11M -778M
Net Debt 4.57M 5.14M 4.23M 3.85M 7.27M 488M 7.39M 50.9M 19.96M 255M 19.29M 18.88M 812M 2.92M 3.28M 2.7M 2.46M 4.64M 311M 4.71M 32.48M 12.73M 162M 12.31M 12.05M 518M
Projected Income Statement - Annual - Implanet SA
Logo Implanet SA
Implanet SA designs, produces, and sells medical implants and devices used in orthopedic surgery. The group's products include spinal bracing systems, intersomatic cages, pins, suture threads, screws, anchors, etc. Net sales break down by activity as follows: - sale of implants and devices for spinal surgery (68.6%); - distribution of medical equipment (31.3%). Net sales are distributed geographically as follows: France (35.6%), the United States (30.8%) and other (33.6%).
Employees
49
Date Price Change Volume
16/10/26 €0.1540 -2.53% 42,544
15/10/26 €0.1580 -3.42% 88,830
14/10/26 €0.1636 -12.04% 375,242
13/10/26 €0.1860 +15.53% 449,700
12/10/26 €0.1610 +1.90% 45,388
  1. Stock Market
  2. Stocks
  3. ALIMP Stock